CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade OXFORD BIOMEDICA PLC ORD 50P - OXB CFD

3.004
1.96%
Market Trading Hours* (UTC) Opens on Wednesday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.072
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.025295 %
Charges from full value of position ($-4.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025295%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003377 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003377%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 3.064
Open 3.048
1-Year Change -29.56%
Day's Range 2.919 - 3.063
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 24, 2024 3.064 0.011 0.36% 3.053 3.108 3.044
Jun 21, 2024 3.063 -0.060 -1.92% 3.123 3.138 3.004
Jun 20, 2024 3.113 0.020 0.65% 3.093 3.168 3.063
Jun 19, 2024 3.108 -0.010 -0.32% 3.118 3.163 3.068
Jun 18, 2024 3.118 0.059 1.93% 3.059 3.213 3.044
Jun 17, 2024 3.029 0.075 2.54% 2.954 3.079 2.954
Jun 14, 2024 3.024 -0.079 -2.55% 3.103 3.113 2.954
Jun 13, 2024 3.103 -0.080 -2.51% 3.183 3.193 3.044
Jun 12, 2024 3.183 -0.070 -2.15% 3.253 3.253 3.128
Jun 11, 2024 3.188 -0.030 -0.93% 3.218 3.248 3.143
Jun 10, 2024 3.218 0.010 0.31% 3.208 3.283 3.148
Jun 7, 2024 3.218 -0.115 -3.45% 3.333 3.333 3.198
Jun 6, 2024 3.333 0.095 2.93% 3.238 3.398 3.143
Jun 5, 2024 3.238 0.030 0.94% 3.208 3.273 3.148
Jun 4, 2024 3.198 -0.030 -0.93% 3.228 3.288 3.183
Jun 3, 2024 3.298 0.070 2.17% 3.228 3.378 3.183
May 31, 2024 3.238 0.080 2.53% 3.158 3.323 3.093
May 30, 2024 3.173 0.075 2.42% 3.098 3.253 3.049
May 29, 2024 3.098 0.005 0.16% 3.093 3.173 3.048
May 28, 2024 3.108 -0.110 -3.42% 3.218 3.263 3.098

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Oxford BioMedica plc Company profile

About Oxford BioMedica plc

Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The Company's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The Company has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.

Financial summary

BRIEF: For the six months ended 30 June 2021, Oxford BioMedica plc revenues increased from £34M to £81.3M. Net income totaled £18.1M vs. loss of £6.7M. Revenues reflect Europe segment increase from £19M to £70.3M. Net Income reflects Platform segment income totaling £24.4M vs. loss of £3.1M. Basic Earnings per Share excluding Extraordinary Items increased from -£0.09 to £0.22.

Equity composition

10/2003, Rights Issue, 27 new shs for every 50 shs held @ GBP 0.17 (Fct:1.54). 03/2001, Rights Issue, 1 new share for every 9 shs held @ GBP 0.55 (Fct:1.111111). 03/1998, Rights Issue, 1 new share for every 4 shs held @ GBP 0.10 (Fct:1.076). 05/2014, Priority Issue, 1 new shares for every 5 shares held @ GBp 2 (Factor:1).

Industry: Bio Therapeutic Drugs

Windrush Court
Transport Way
OXFORD
OXFORDSHIRE OX4 6LT
GB

News

Bank of England preview: no rate cut just yet despite CPI returning to 2%

The Bank of England (BoE) is widely expected to keep rates unchanged when it meets on Thursday. Analyst Daniela Harthorn looks at what this could mean

12:45, 18 June 2024

RBA Meeting Preview: No change to policy expected, markets look for fresh guidance

The Reserve Bank of Australia is expected to keep interest rates unchanged at 4.35% when it meets on Tuesday, June 18th, 2024, at 2:30 PM (AEST).

13:17, 17 June 2024

FOMC Decision Review: Rates unchanged as central bank raises inflation and interest rate forecasts

The FOMC left Federal Funds Rate unchanged at a target range of 5.25 to 5.50%.

10:55, 17 June 2024

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

People also watch

US100

19,701.00 Price
+1.120% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

62,055.10 Price
+4.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,319.44 Price
-0.700% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee 0.0111%
Overnight fee time 21:00 (UTC)
Spread 0.40

XRP/USD

0.48 Price
+2.160% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading